Evidence map›Paper›PMID 30894705›Full record

ReviewGenetics in medicine : official journal of the American College of Medical Genetics2019

A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses.

Erica D Smith, Kirsten Blanco, Samin A Sajan, Jesse M Hunter, Deepali N Shinde, Bess Wayburn, Mari Rossi, Jennifer Huang, Cathy A Stevens, Candace Muss and 4 more

Abstract readReview
In one paragraph

Review in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Navigating an Uninformative Genomic Test Result: A Practical Guide.Journal of paediatrics and child health · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Erica D SmithClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Kirsten BlancoClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Samin A SajanClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Jesse M HunterClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Deepali N ShindeClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Bess WayburnClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Mari RossiClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Jennifer HuangClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Cathy A StevensChildren's Hospital at Erlanger, Chattanooga, TN, USA.
Candace MussChildren's Hospital at Erlanger, Chattanooga, TN, USA.
Wendy AlcarazClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Kelly D Farwell HagmanClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Sha TangClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA.
Kelly RadtkeClinical Genomics, Ambry Genetics, Aliso Viejo, CA, USA. kradtke@ambrygen.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe evaluated clinical and genetic features enriched in patients with multiple Mendelian conditions to determine which patients are more likely to have multiple potentially relevant genetic findings (MPRF).

methodsResults of the first 7698 patients who underwent exome sequencing at Ambry Genetics were reviewed. Clinical and genetic features were examined and degree of phenotypic overlap between the genetic diagnoses was evaluated.

resultsAmong patients referred for exome sequencing, 2% had MPRF. MPRF were more common in patients from consanguineous families and patients with greater clinical complexity. The difference in average number of organ systems affected is small: 4.3 (multiple findings) vs. 3.9 (single finding) and may not be distinguished in clinic.

conclusionPatients with multiple genetic diagnoses had a slightly higher number of organ systems affected than patients with single genetic diagnoses, largely because the comorbid conditions affected overlapping organ systems. Exome testing may be beneficial for all cases with multiple organ systems affected. The identification of multiple relevant genetic findings in 2% of exome patients highlights the utility of a comprehensive molecular workup and updated interpretation of existing genomic data; a single definitive molecular diagnosis from analysis of a limited number of genes may not be the end of a diagnostic odyssey.

Indexed as

Diagnosis, DifferentialDiagnostic Techniques and ProceduresExomeExome SequencingFemaleGenetic TestingGenomicsGenotypeHigh-Throughput Nucleotide SequencingHumansMaleMutationPhenotypeRetrospective StudiesSequence Analysis, DNAcomorbiditydiagnostic exome sequencingdistinct vs. overlapping phenotypesmultilocus genomic variationmultiple genetic diseases

Identifiers

PMID30894705
PMCPMC6774997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.